中药联合糖皮质激素治疗系统性红斑狼疮系统评价与Meta分析OA
Systematic Review and Meta-Analysis of Chinese Herbal Medicine Combined with Glucocorticoids in the Treatment of Systemic Lupus Erythematosus
目的:采用Meta分析方法系统评价中药联合糖皮质激素治疗系统性红斑狼疮(systematic lupus erythe-matosus,SLE)的临床疗效与安全性.方法:检索中国知网、维普数据库、万方数据库、中国生物医学文献服务系统及公共医学图书馆数据库,收集中西药联合治疗SLE的随机对照试验,按照预设的文献纳入与排除标准及结局指标筛选文献,采用RevMan 5.3软件进行Meta分析.主要结局指标为临床治疗有效率;次要结局指标包括SLE疾病活动度评分、不良反应发生率及实验室检查指标[外周血白细胞计数、补体C3水平].结果:共纳入随机对照试验24篇,累计患者2074例.Meta分析结果显示,与对照组相比,中西药联合治疗SLE可显著提高临床疗效(RR=1.17,95%CI:1.13~1.22,P<0.000 01),降低SLE疾病活动度评分(MD=-1.83,95%CI:-2.09~-1.58,P<0.000 01),升高外周血白细胞计数(MD=0.76,95%CI:0.58~0.94,P<0.000 01)、补体C3水平(MD=0.11,95%CI:0.05~0.17,P=0.0003).联合治疗组的药物不良反应发生率显著低于对照(RR=0.43,95%CI:0.25~0.72,P<0.000 01).结论:与单用糖皮质激素治疗相比,中药联合糖皮质激素治疗SLE可显著提高临床有效率,降低SLE疾病活动度评分,升高外周血白细胞计数及补体C3水平,并显著降低药物不良反应发生率.受纳入研究质量参差不齐、随访周期较短等因素限制,仍需开展更多高质量、长期随访的随机对照试验,进一步验证本研究结论.
Objective:This study used a meta-analysis to systematically evaluate the clinical efficacy and safety of Chinese herbal medicine combined with glucocorticoids in the treatment of systemic lupus erythematosus(SLE).Methods:We searched CNKI,VIP and Wanfang,CBM and the PubMed database to collect RCTs on the combined treatment of SLE with integrated traditional Chinese and Western medicine,we screened the literature according to pre-established inclusion and exclusion criteria and outcome indicators,and performed a Meta-analysis using RevMan 5.3 software.The primary outcome indicator is the clinical effective rate,and secondary outcome indicators include the SLE disease activity score,the incidence of adverse reactions,and laboratory examination indicators[peripheral blood white blood cell count,complement C3 level].Results:A total of 24 RCTs involving 2074 patients were included.The Meta-analysis results showed that compared with the control group,combined treatment with traditional Chinese and Western medicine for SLE significantly improved clinical efficacy(RR=1.17,95%CI:1.13~1.22,P<0.000 01),reduced the SLE disease activity score(MD=-1.83,95%CI:-2.09~-1.58,P<0.000 01),increased the peripheral blood white blood cell count(MD=0.76,95%CI:0.58~0.94,P<0.000 01),and elevated complement C3 levels(MD=0.11,95%CI:0.05,0.17,P=0.0003).The incidence of adverse drug reactions in the combined treatment group was significantly lower than that in the control group(RR=0.43,95%CI:0.25~0.72,P<0.000 01).Conclusion:Compared with glucocorticoid monotherapy,the combination of traditional Chinese medicine and glucocorticoids for the treatment of SLE can significantly improve the clinical effective rate,reduce the SLE disease activity score,increase the peripheral blood white blood cell count and complement C3 level,and significantly decrease the incidence of adverse drug reactions.However,limited by factors such as the varying quality of the included studies and the relatively short follow-up periods,more high-quality,long-term follow-up RCTs are still needed to further validate the conclusions of this study.
成雪莉;钟正宏;赖家文;刘靖
广州中医药大学深圳医院(福田),广东 广州 518000澳门科技大学中医药学院中药质量研究国家重点实验室,澳门 999078广州中医药大学第一附属医院,广东 广州 510405广州中医药大学第一附属医院,广东 广州 510405
医药卫生
系统性红斑狼疮中西医结合疗效安全性系统评价Meta分析
systemic lupus erythematosusintegrated traditional Chinese and Western medicineclinical effectssafetysystematic evaluationMeta analysis
《西部中医药》 2026 (4)
68-73,6
国家自然科学基金面上项目(81573980)国家自然科学基金青年基金项目(81202099)广东省中医药管理项目(20213006).
评论